Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin

Gynecologic Oncology

Volumn 136, Issue 3, 2015, Pages 562-566

  Stiekema, A ^a   Boldingh, Q J A J ^a   Korse, C M ^b   Van Der Noort, V ^b   Boot, H ^a   Van Driel, W J ^a   Kenter, G G ^a   Lok, C A R ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CA125; CEA; Epithelial ovarian cancer; HE4; Ovarian metastases

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4; PROTEIN; TUMOR MARKER; WFDC2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; OVARY CLEAR CELL CARCINOMA; OVARY METASTASIS; OVARY MUCINOUS ADENOCARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERUM; TUMOR DIFFERENTIATION; UNIVARIATE ANALYSIS; ADENOCARCINOMA; AREA UNDER THE CURVE; BLOOD; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; GASTROINTESTINAL NEOPLASMS; METABOLISM; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; STATISTICAL MODEL; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTEINS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84924239001     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.037     Document Type: Article

References (19)

1. (NKR) DCR http://www.cijfersoverkanker.nl [consulted on July 25th 2014]
2. E.P.H. Petru, H. Pickel, M. Heydarfadai, M. Lahousen, J. Haas, and H. Schaider Nongenital cancers metastatic to the ovary Gynecol Oncol 44 1 1992 83 86
3. T.M. Ulbright, L.M. Roth, and F.B. Stehman Secondary ovarian neoplasia. A clinicopathologic study of 35 cases Cancer 53 5 1984 1164 1174
4. R.H. Young, and R.E. Scully Metastatic tumors in the ovary: a problem-oriented approach and review of the recent literature Semin Diagn Pathol 8 4 1991 250 276
5. R.I. Demopoulos, L. Touger, and N. Dubin Secondary ovarian carcinoma: a clinical and pathological evaluation Int J Gynecol Pathol 6 1987 166 175
6. J. Pitt, and P.M. Dawson Oophorectomy in women with colorectal cancer Eur J Surg Oncol 25 1999 432 438
7. M.R. Lewis, M.T. Deavers, E.G. Silva, and A. Malpica Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge Am J Surg Pathol 30 2006 177 184
8. Y.R. de Waal, C.M.G. Thomas, A.L.M. Oei, F.C.G.J. Sweep, and L.F.A.G. Massuger Secondary ovarian malignancies: frequency, origin, and characteristics Int J Gynecol Cancer 19 7 2009 1160 1165
9. M.R. Lewis, E.D. Euscher, M.T. Deavers, E.G. Silva, and A. Malpica Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall Gynecol Oncol 105 2 2007 395 398
10. S.J. Lee, J.H. Bae, A.W. Lee, S.Y. Tong, Y.G. Park, and J.S. Park Clinical characteristics of metastatic tumors to the ovaries J Korean Med Sci 24 1 2009 114 119
11. R. Antila, J. Jalkanen, and O. Heikinheimo Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics Gynecol Oncol 101 1 2006 97 101
12. S.S. Sorensen, and B.J. Mosgaard Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis Dan Med Bull 58 11 2011 A4331
13. A. Stiekema, C.A.R. Lok, G.G. Kenter, W.J. van Driel, A.D. Vincent, and C.M. Korse A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer Gynecol Oncol 132 2014 573 577
14. P.A. van Noord, J.S. Dubas, M. Dorland, H. Boersma, and E. te Velde Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity and lifestyle factors Fertil Steril 68 1 1997 95 102
15. J.M.G. Bonfrer, C.M. Korse, R.A. Verstraeten, G.J. van Kamp, G.A.M. Hart, and P. Kenemans Clinical evaluation of Byk LIA-mat CA125 II assay: discussion of a reference value Clin Chem 43 3 1997 491 497
16. R.G. Moore, M.C. Miller, E.E. Eklund, K.H. Lu, R.C. Bast Jr., and G. Lambert-Messerlian Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age Am J Obstet Gynecol 206 4 2012 [349.e1-7]
17. R.G. Moore, D.S. McMeekin, A.K. Brown, P. DiSilvestro, M.C. Miller, and W.J. Allard A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecol Oncol 112 2009 40 46
18. P.K. Buamah, M.O. Rake, S.R. Drake, and A.W. Skillen Serum CA125 concentrations and CA125/CEA ratios in patients with epithelial ovarian cancer J Surg Oncol 44 1990 97 99
19. C.A. Yedema, P. Kenemans, T. Wobbes, C.M. Thomas, G.G. Bon, and C. Mulder Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas Tumour Biol 13 1-2 1992 18 26